Provectus Biopharmaceuticals (PVCT) Research & Development (2010 - 2026)
Provectus Biopharmaceuticals (PVCT) posted Research & Development of $131,130 for Q2 2026, down 85.1% from $880,835 a year earlier.
Powered by 
Analysis
Provectus Biopharmaceuticals (PVCT) Research & Development (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Provectus Biopharmaceuticals was $1.63 million, down 29.0% year-over-year; for FY2025, it came in at $1.9 million, down 7.5% from FY2024.
- Annual Research & Development shows a five-year compound annual growth rate of -7.6% (FY2020 to FY2025).
- In prior years, Provectus Biopharmaceuticals' Research & Development was $2.05 million in FY2024 (+17.2%), $1.75 million in FY2023 (-26.8%), $2.39 million in FY2022 (-8.4%) and $2.61 million in FY2021 (-7.3%).
- The Q2 2026 figure stands as the lowest quarterly Research & Development in data going back to Q2 2010.
- On a year-over-year basis, Research & Development increased in three of the last seven quarters, with an average decline of 5.3%.
- The strongest year-over-year quarter for Research & Development in the past five years was Q2 2025, with growth of 86.3%; the weakest was Q2 2026, with a decline of 85.1%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Provectus Biopharmaceuticals | 19.16 Mn | 17.27 Mn | - | 131,130.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 131,130.00 |
| Dec 31, 2025 | 268,428.00 |
| Sep 30, 2025 | 345,861.00 |
| Jun 30, 2025 | 880,835.00 |
| Mar 31, 2025 | 388,810.00 |
| Dec 31, 2024 | 608,214.00 |
| Sep 30, 2024 | 413,987.00 |
| Jun 30, 2024 | 472,927.00 |
| Mar 31, 2024 | 555,535.00 |
| Dec 31, 2023 | 415,841.00 |
| Sep 30, 2023 | 350,792.00 |
| Jun 30, 2023 | 434,214.00 |
| Mar 31, 2023 | 548,393.00 |
| Dec 31, 2022 | 321,206.00 |
| Sep 30, 2022 | 580,390.00 |
| Jun 30, 2022 | 816,648.00 |
| Mar 31, 2022 | 671,116.00 |
| Dec 31, 2021 | 741,581.00 |
| Sep 30, 2021 | 608,653.00 |
| Jun 30, 2021 | 602,979.00 |
API Access
Provectus Biopharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=PVCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "PVCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=PVCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();